ROCKVILLE, Md. & VIENNA, Austria--(BUSINESS WIRE)--April 26, 2006--Celera Genomics (NYSE:CRA - News), an Applera Corporation business, today announced the presentation of data supporting a multi-gene Genetic Risk Score that predicts future risk of developing cirrhosis in patients with chronic hepatitis C (CHC). The presentation will be made on April 28, 2006 at the 41st annual meeting of The European Association for the Study of the Liver, in Vienna, Austria.
